Dysphagia laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Feham Tariq (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
| Line 11: | Line 11: | ||
Such diseases include the following:<ref name="pmid15778537">{{cite journal| author=Sagar R, Varghese ST, Balhara YP| title=Dysphagia due to olanzepine, an antipsychotic medication. | journal=Indian J Gastroenterol | year= 2005 | volume= 24 | issue= 1 | pages= 37-8 | pmid=15778537 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15778537 }} </ref><ref name="pmid27543610">{{cite journal| author=Osman M, Devadas V| title=Clozapine-induced dysphagia with secondary substantial weight loss. | journal=BMJ Case Rep | year= 2016 | volume= 2016 | issue= | pages= | pmid=27543610 | doi=10.1136/bcr-2016-216445 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27543610 }} </ref> | Such diseases include the following:<ref name="pmid15778537">{{cite journal| author=Sagar R, Varghese ST, Balhara YP| title=Dysphagia due to olanzepine, an antipsychotic medication. | journal=Indian J Gastroenterol | year= 2005 | volume= 24 | issue= 1 | pages= 37-8 | pmid=15778537 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15778537 }} </ref><ref name="pmid27543610">{{cite journal| author=Osman M, Devadas V| title=Clozapine-induced dysphagia with secondary substantial weight loss. | journal=BMJ Case Rep | year= 2016 | volume= 2016 | issue= | pages= | pmid=27543610 | doi=10.1136/bcr-2016-216445 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27543610 }} </ref> | ||
*Myasthenia gravis | *[[Myasthenia gravis]] | ||
*Thyrotoxicosis | *[[Thyrotoxicosis]] | ||
*Inflammatory myopathies | *[[Myopathies|Inflammatory myopathies]] | ||
*Toxic myopathies | *[[Myopathies|Toxic myopathies]] | ||
Following laboratory tests are done for the diagnosis of these diseases:<ref name="pmid11677277">{{cite journal| author=Bakheit AM| title=Management of neurogenic dysphagia. | journal=Postgrad Med J | year= 2001 | volume= 77 | issue= 913 | pages= 694-9 | pmid=11677277 | doi= | pmc=1742185 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11677277 }} </ref><ref name="pmid26711168">{{cite journal| author=Malandraki GA, Rajappa A, Kantarcigil C, Wagner E, Ivey C, Youse K| title=The Intensive Dysphagia Rehabilitation Approach Applied to Patients With Neurogenic Dysphagia: A Case Series Design Study. | journal=Arch Phys Med Rehabil | year= 2016 | volume= 97 | issue= 4 | pages= 567-574 | pmid=26711168 | doi=10.1016/j.apmr.2015.11.019 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26711168 }} </ref> | Following laboratory tests are done for the diagnosis of these diseases:<ref name="pmid11677277">{{cite journal| author=Bakheit AM| title=Management of neurogenic dysphagia. | journal=Postgrad Med J | year= 2001 | volume= 77 | issue= 913 | pages= 694-9 | pmid=11677277 | doi= | pmc=1742185 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11677277 }} </ref><ref name="pmid26711168">{{cite journal| author=Malandraki GA, Rajappa A, Kantarcigil C, Wagner E, Ivey C, Youse K| title=The Intensive Dysphagia Rehabilitation Approach Applied to Patients With Neurogenic Dysphagia: A Case Series Design Study. | journal=Arch Phys Med Rehabil | year= 2016 | volume= 97 | issue= 4 | pages= 567-574 | pmid=26711168 | doi=10.1016/j.apmr.2015.11.019 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26711168 }} </ref> | ||
*Acetylcholine receptor (AChR) antibodies | *Acetylcholine receptor (AChR) antibodies | ||
*Thyroid function tests | *[[Thyroid function tests]] | ||
*Muscle enzyme essays | *Muscle enzyme essays | ||
Revision as of 16:48, 23 February 2018
|
Dysphagia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dysphagia laboratory findings On the Web |
|
American Roentgen Ray Society Images of Dysphagia laboratory findings |
|
Risk calculators and risk factors for Dysphagia laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2] Feham Tariq, MD [3]
Overview
There are no diagnostic laboratory findings associated with dysphagia.
Laboratory Findings
There are no diagnostic laboratory findings associated with dysphagia per se. However, in certain diseases leading to dysphagia, laboratory evaluation is done to look for the underlying disease.
Such diseases include the following:[1][2]
Following laboratory tests are done for the diagnosis of these diseases:[3][4]
- Acetylcholine receptor (AChR) antibodies
- Thyroid function tests
- Muscle enzyme essays
References
- ↑ Sagar R, Varghese ST, Balhara YP (2005). "Dysphagia due to olanzepine, an antipsychotic medication". Indian J Gastroenterol. 24 (1): 37–8. PMID 15778537.
- ↑ Osman M, Devadas V (2016). "Clozapine-induced dysphagia with secondary substantial weight loss". BMJ Case Rep. 2016. doi:10.1136/bcr-2016-216445. PMID 27543610.
- ↑ Bakheit AM (2001). "Management of neurogenic dysphagia". Postgrad Med J. 77 (913): 694–9. PMC 1742185. PMID 11677277.
- ↑ Malandraki GA, Rajappa A, Kantarcigil C, Wagner E, Ivey C, Youse K (2016). "The Intensive Dysphagia Rehabilitation Approach Applied to Patients With Neurogenic Dysphagia: A Case Series Design Study". Arch Phys Med Rehabil. 97 (4): 567–574. doi:10.1016/j.apmr.2015.11.019. PMID 26711168.